Expertise in
4
conditions

Shuanying M. Yang

No. 157 Xiwu Road, 
Xi'an, CN 
Expertise in
4
conditions
No. 157 Xiwu Road, 
Xi'an, CN 

Overview

Shuanying Yang practices practicing medicine in Xi'an, China.

Yang is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Lung Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, and Gamma Knife Radiosurgery.

They are actively involved in clinical research, co-authoring 105 peer reviewed articles and participating in 4 clinical trials.

Locations

No. 157 Xiwu Road, Xi'an, 710004, China
Other Locations
157th Xiwu Road, Xi'an, 710000, China
P.r, Xi'an, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Device, Drug
Study Drugs: FF/VI, FF/UMEC/VI
Study Phase: Phase 3
COPD Disease Burden, Patient Characteristics, Maintenance Treatment Patterns and Factors Influencing Treatment Decisions in China Tier 2 and Tier 3 Hospitals
COPD Disease Burden, Patient Characteristics, Maintenance Treatment Patterns and Factors Influencing Treatment Decisions in China Tier 2 and Tier 3 Hospitals
Enrollment Status: Completed
Publish Date: December 06, 2024
Intervention Type: Other
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
View 3 Less Clinical Trials

105 Total Publications

Reversing Enamel Mineralization Inhibition Using Amyloid-like Protein Film.
Reversing Enamel Mineralization Inhibition Using Amyloid-like Protein Film.
Journal: Journal of dental research
Published: July 17, 2026

Frequently Asked Questions about Shuanying M. Yang

Is Shuanying M. Yang a top-rated expert for Lung Adenocarcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Shuanying M. Yang is classified as an Advanced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shuanying M. Yang participate in research or clinical trials?

Yes. Shuanying M. Yang has published 105 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Shuanying M. Yang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yang's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile